These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30768268)
1. SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK). Asquith CRM; Berger BT; Wan J; Bennett JM; Capuzzi SJ; Crona DJ; Drewry DH; East MP; Elkins JM; Fedorov O; Godoi PH; Hunter DM; Knapp S; Müller S; Torrice CD; Wells CI; Earp HS; Willson TM; Zuercher WJ J Med Chem; 2019 Mar; 62(5):2830-2836. PubMed ID: 30768268 [TBL] [Abstract][Full Text] [Related]
2. Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma. Asquith CRM; Naegeli KM; East MP; Laitinen T; Havener TM; Wells CI; Johnson GL; Drewry DH; Zuercher WJ; Morris DC J Med Chem; 2019 May; 62(9):4772-4778. PubMed ID: 30973735 [TBL] [Abstract][Full Text] [Related]
3. Targeting the Water Network in Cyclin G-Associated Kinase (GAK) with 4-Anilino-quin(az)oline Inhibitors. Asquith CRM; Tizzard GJ; Bennett JM; Wells CI; Elkins JM; Willson TM; Poso A; Laitinen T ChemMedChem; 2020 Jul; 15(13):1200-1215. PubMed ID: 32358915 [TBL] [Abstract][Full Text] [Related]
4. Cyclin G-associated kinase (GAK) affinity and antiviral activity studies of a series of 3-C-substituted isothiazolo[4,3-b]pyridines. Wouters R; Pu SY; Froeyen M; Lescrinier E; Einav S; Herdewijn P; De Jonghe S Eur J Med Chem; 2019 Feb; 163():256-265. PubMed ID: 30529544 [TBL] [Abstract][Full Text] [Related]
5. Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents. Kovackova S; Chang L; Bekerman E; Neveu G; Barouch-Bentov R; Chaikuad A; Heroven C; Šála M; De Jonghe S; Knapp S; Einav S; Herdewijn P J Med Chem; 2015 Apr; 58(8):3393-410. PubMed ID: 25822739 [TBL] [Abstract][Full Text] [Related]
6. The cyclin G-associated kinase (GAK) inhibitor SGC-GAK-1 inhibits neurite outgrowth and synapse formation. Egawa J; Arta RK; Lemmon VP; Muños-Barrero M; Shi Y; Igarashi M; Someya T Mol Brain; 2022 Jul; 15(1):68. PubMed ID: 35883152 [TBL] [Abstract][Full Text] [Related]
7. Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK). Asquith CRM; Bennett JM; Su L; Laitinen T; Elkins JM; Pickett JE; Wells CI; Li Z; Willson TM; Zuercher WJ Molecules; 2019 Nov; 24(22):. PubMed ID: 31698822 [TBL] [Abstract][Full Text] [Related]
8. Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking. Susa M; Choy E; Liu X; Schwab J; Hornicek FJ; Mankin H; Duan Z Mol Cancer Ther; 2010 Dec; 9(12):3342-50. PubMed ID: 20881269 [TBL] [Abstract][Full Text] [Related]
9. GAK, a regulator of clathrin-mediated membrane trafficking, localizes not only in the cytoplasm but also in the nucleus. Sato J; Shimizu H; Kasama T; Yabuta N; Nojima H Genes Cells; 2009 May; 14(5):627-41. PubMed ID: 19371378 [TBL] [Abstract][Full Text] [Related]
10. Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase. Asquith CRM; Laitinen T; Bennett JM; Godoi PH; East MP; Tizzard GJ; Graves LM; Johnson GL; Dornsife RE; Wells CI; Elkins JM; Willson TM; Zuercher WJ ChemMedChem; 2018 Jan; 13(1):48-66. PubMed ID: 29072804 [TBL] [Abstract][Full Text] [Related]
11. The serine/threonine kinase cyclin G-associated kinase regulates epidermal growth factor receptor signaling. Zhang L; Gjoerup O; Roberts TM Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10296-301. PubMed ID: 15240878 [TBL] [Abstract][Full Text] [Related]
12. Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase. Martinez-Gualda B; Saul S; Froeyen M; Schols D; Herdewijn P; Einav S; De Jonghe S Eur J Med Chem; 2021 Mar; 213():113158. PubMed ID: 33497888 [TBL] [Abstract][Full Text] [Related]
14. GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain. Kanaoka Y; Kimura SH; Okazaki I; Ikeda M; Nojima H FEBS Lett; 1997 Jan; 402(1):73-80. PubMed ID: 9013862 [TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics. Miyazaki M; Hiramoto M; Takano N; Kokuba H; Takemura J; Tokuhisa M; Hino H; Kazama H; Miyazawa K Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34468012 [TBL] [Abstract][Full Text] [Related]
16. GAK, a regulator of clathrin-mediated membrane traffic, also controls centrosome integrity and chromosome congression. Shimizu H; Nagamori I; Yabuta N; Nojima H J Cell Sci; 2009 Sep; 122(Pt 17):3145-52. PubMed ID: 19654208 [TBL] [Abstract][Full Text] [Related]
17. A kinome-wide siRNA screen identifies multiple roles for protein kinases in hypoxic stress adaptation, including roles for IRAK4 and GAK in protection against apoptosis in VHL-/- renal carcinoma cells, despite activation of the NF-κB pathway. Pan J; Zhang J; Hill A; Lapan P; Berasi S; Bates B; Miller C; Haney S J Biomol Screen; 2013 Aug; 18(7):782-96. PubMed ID: 23591012 [TBL] [Abstract][Full Text] [Related]
18. Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK). Asquith CRM; Treiber DK; Zuercher WJ Bioorg Med Chem Lett; 2019 Jul; 29(14):1727-1731. PubMed ID: 31129055 [TBL] [Abstract][Full Text] [Related]
19. GAK is phosphorylated by c-Src and translocated from the centrosome to chromatin at the end of telophase. Fukushima K; Wang M; Naito Y; Uchihashi T; Kato Y; Mukai S; Yabuta N; Nojima H Cell Cycle; 2017 Mar; 16(5):415-427. PubMed ID: 28135906 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of isothiazolo[4,5- Ivanova Y; Spittaels S; Gao LJ; Schols D; Van Meervelt L; Froeyen M; Dehaen W; De Jonghe S Org Biomol Chem; 2024 Sep; 22(36):7373-7389. PubMed ID: 39171941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]